Archives
-
T7 RNA Polymerase: IVT Mechanism and Workflow
2026-09-09
T7 RNA Polymerase is a recombinant enzyme expressed in E. coli that produces RNA from DNA templates carrying a T7 promoter. Its defined template specificity supports in vitro transcription, including RNA synthesis from linearized plasmid templates, while the referenced 2026 bladder cancer study illustrates how IVT mRNA can support localized therapeutic research.
-
Cabazitaxel (XRP6258): Practical Lab Guide
2026-09-08
Cabazitaxel (XRP6258, SKU B2157) is a semi-synthetic taxane derivative for studying microtubule dynamics disruption, including work with P-glycoprotein-expressing or taxane-resistant cancer cell lines. It is intended for DMSO- or ethanol-based workflows, is insoluble in water, and should not be kept as a long-term solution.
-
Bazedoxifene Workflows for Osteoporosis Research
2026-09-08
Bazedoxifene enables tissue-selective estrogen receptor studies that connect ER signaling, breast-cell proliferation, and bone-focused assay design. This practical guide covers formulation, dose-response workflows, translational interpretation, and troubleshooting for osteoporosis treatment research.
-
Plant-Virus m6A Antagonism in CMV Infection
2026-09-07
A 2025 Nature Communications study reveals that RNA m6A modification is an active battleground between cucumber mosaic virus and its plant host. The work links viral RNA methylation, ECT8-mediated RNA destabilization, and CMV 2b-mediated disruption of the host methyltransferase complex, while also clarifying how protein-preserving workflows can support complementary mechanistic assays.
-
β-Amanitin Workflows for Transcription Research
2026-09-07
Use β-Amanitin as a focused RNA polymerase II perturbation tool for transcriptional regulation research, mRNA synthesis inhibition assays, and amatoxin toxicology workflows. A complementary mushroom-biosensing study shows how β-amatoxin recognition can be translated into rapid dual-target screening without confusing a functional inhibitor with an immunoassay calibrant.
-
MHY1485: mTOR Activator for Autophagy Assays
2026-09-05
MHY1485 provides a practical way to activate mTOR while testing autophagosome accumulation, cell-state changes, and ovarian follicle responses. Its value is greatest in paired, time-resolved workflows that distinguish true flux changes from blocked autophagosome-lysosome fusion.
-
SM-164: IAP Biology Meets Pol II Death
2026-09-04
SM-164 is a bivalent Smac mimetic that enables a sharper analysis of IAP-regulated, TNFα-dependent apoptosis. This article connects its pharmacology with new RNA Pol II death biology to improve assay interpretation in cancer research.
-
Pemetrexed Workflows for Tumor Cell Research
2026-09-04
Build reproducible pemetrexed assays that connect folate-pathway inhibition with viability, apoptosis, and DNA-repair phenotypes. The workflow is especially useful for cancer chemotherapy research, including biomarker-guided studies in malignant mesothelioma and non-small cell lung carcinoma models.
-
Hesperadin as a Molecular Lens on Mitotic Checkpoints
2026-09-03
Hesperadin is an Aurora B kinase inhibitor that can separate chromosome-control defects from mitotic checkpoint biochemistry. This article connects its assay behavior with the Plk1–p31comet–TRIP13 mechanism and provides a practical framework for interpreting cell-cycle experiments.
-
Pheromone Signaling and Neurodegeneration in C. elegans
2026-09-03
Peng et al. show that pheromone exposure during the L1 stage can reprogram neural circuitry in C. elegans and increase neurodegeneration later in life. The study identifies coordinated signaling through ASK, ASI, AIA interneurons, insulin-like signaling, and neuronal autophagy, providing a mechanistic link between early chemical experience and adult proteostasis failure.
-
Streptavidin-FITC for Biotin Tracking Workflows
2026-09-02
Streptavidin-FITC converts biotinylated antibodies, nucleic acids, and nanoparticles into visible fluorescent signals across tissue imaging, cell analysis, and trafficking studies. This guide combines practical staining workflows with assay controls inspired by recent lipid nanoparticle research.
-
EGTA (Egtazic Acid) for Calcium Signaling
2026-09-02
EGTA, also called egtazic acid, is a selective aminopolycarboxylic acid calcium chelator used to lower free calcium in biochemical and cellular experiments. Its strongest interpretive value is causal testing of calcium dependence, while its limited solubility and extracellular bias constrain protocol design.
-
Firefly Luciferase mRNA Workflow Guide
2026-09-01
Firefly Luciferase mRNA provides a sensitive, nonradioactive readout for transfection, gene expression, viability, and delivery studies. Its ARCA cap, 5mCTP, ΨUTP, and approximately 100-nucleotide poly(A) tail support practical workflows that require consistent signal with reduced innate immune stimulation.
-
Aminopeptidase Selectivity of ACE Inhibitors
2026-09-01
This 1992 study directly compared metallopeptidase inhibitors across porcine kidney aminopeptidases A, N, and W, revealing substantial differences in selectivity that were obscured by overlapping substrate specificities. Its findings provide an important assay-design framework: ACE inhibitor effects on related zinc peptidases should be verified experimentally rather than inferred from inhibitor class alone.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-31
The 1986 study by Rack, Rubly, and Waschow used voltage-clamped frog nerve fibers to compare Halazone with chemically distinct reagents that alter sodium-current inactivation. Its key contribution was to show that the oxidant-induced phenotype did not support a uniquely critical methionine residue and instead pointed cautiously toward membrane-lipid modification as a possible explanation.